Akorn Inc. | |
Stock Exchange | Frankfurt Stock Exchange |
EPS |
- |
Market Cap |
- |
Shares Outstanding |
125.45 M |
Public Float |
93.65 M |
Akorn Inc. | |
Stock Exchange | NASDAQ Stock Market |
EPS |
$3.63 |
Market Cap |
$638.06 M |
Shares Outstanding |
125.85 M |
Public Float |
91.78 M |
Address |
1925 West Field Court Lake Forest Illinois 60045 United States |
Employees | - |
Website | http://www.akorn.com |
Updated | 07/08/2019 |
Akorn, Inc. operates as a niche pharmaceutical company that develops, manufactures and markets generic and prescription pharmaceuticals, as well as, animal and consumer health products. It operates through the Prescription Pharmaceuticals and Consumer Health segments. The Prescription Pharmaceuticals segment engages in the sales of generic and branded prescription pharmaceuticals including ophthalmics, injectables, oral liquids, otics, topicals, inhalants, and nasal sprays. |